Insider Trading: Isis Pharmaceuticals Inc (ISIS.O)

ISIS.O on Nasdaq

20.66USD
17 May 2013
Price Change (% chg)

$0.50 (+2.48%)
Prev Close
$20.16
Open
$20.30
Day's High
$20.75
Day's Low
$20.07
Volume
1,729,851
Avg. Vol
1,619,117
52-wk High
$23.03
52-wk Low
$7.55

Search Stocks
GEARY RICHARD S Options Exercised: 0
Trade Date: Sunday, 8 Jul 2012 Price: 13.45
Title: Officer Shares Held: 3,190
Type Traded: Direct Net Change in Shares This Filing: 0

Institutional Holders

% Shares Owned: 78.31%
# of Holders: 213
Total Shares Held: 87,467,751
3 Mo. Net Change: 6,527,321
# New Positions: 51
# Closed Positions: 19
# Increased Positions: 100
# Reduced Positions: 84
# Net Buyers: 16

Officers & Directors

Name Age Since Current Position

Stanley Crooke

67 1991 Chairman of the Board, President, Chief Executive Officer

Elizabeth Hougen

51 2013 Chief Financial Officer, Senior Vice President - Finance

B. Lynne Parshall

58 2013 Chief Operating Officer, Corporate Secretary, Director

Patrick O'Neil

39 2013 Senior Vice President - Legal, General Counsel

C. Frank Bennett

56 2006 Senior Vice President - Antisense Research

Richard Geary

55 2008 Senior Vice President - Development

Brett Monia

51 2012 Senior Vice President - Drug Discovery and Corporate Development

Spencer Berthelsen

60 2002 Independent Director

Joseph Klein

51 2005 Independent Director

Frederick Muto

2001 Independent Director

Joseph Wender

67 1994 Independent Director

Wade Walke

Executive Director - Corporate Communications
Search Stocks